GlassScriptPhysician profile
Nicholas Chang
NPI 1265094700
$5,844.43
in general payments reported to CMS, 2019-2025
17 companies · $3,482 in 2025
The $3,482 reported for 2025 was more than what 91% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $134 · 2023: $1,987 · 2024: $242 · 2025: $3,482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,639 · Food and Beverage: $2,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,639.03 |
| Food and Beverage | $2,071.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,260.81 | 2023-2025 | Pico, Grafix, Collagenase Santyl |
| Treace Medical Concepts, INC. | $957.72 | 2023-2025 | |
| Arthrex, INC. | $572.99 | 2025 | |
| Stryker Corporation | $534.10 | 2022-2023 | Prostep |
| Paragon 28, INC. | $495.89 | 2023-2024 | Portfolio, Precision Mis Bunion |
| Invictus Surgical Incorporated | $418.81 | 2024-2025 | |
| Organogenesis INC. | $154.37 | 2022-2025 | Puraply, Cygnus Dual |
| Paratek Pharmaceuticals, INC. | $93.45 | 2025 | Nuzyra |
| Fusion Orthopedics USA, LLC | $77.56 | 2025 | |
| Bioventus LLC | $53.95 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Next Science LLC | $51.39 | 2023 | Xperience, Blastx, Surgx |
| Orthofix Medical, INC. | $45.99 | 2024-2025 | Physio-Stim |
| Averitas Pharma INC. | $38.17 | 2023-2024 | Qutenza |
| Musculoskeletal Transplant Foundation INC. | $26.16 | 2023 | |
| Kci USA, INC. | $22.69 | 2023 | Promogran Prisma, V.A.C. Dermatac, 3m Cavilon |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $22.53 | 2025 | |
| Abbvie INC. | $17.85 | 2023 | Dalvance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.